BLFS
BioLife Solutions Inc
NASDAQ: BLFS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$21.08
+5.45% today
Updated 2026-04-30
Market cap
$976.66M
P/E ratio
—
P/S ratio
10.15x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$18 – $30
Volume
0.4M
BioLife Solutions Inc (BLFS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-4.78%
Operating margin
-0.32%
ROE
-3.37%
ROA
-0.17%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $603219.00 | $-1.13M | 50.59% | -247.73% | -187.99% |
| 2007 | $972262.00 | $-2.85M | 52.37% | -279.09% | -293.31% |
| 2008 | $1.32M | $-2.78M | 41.73% | -186.27% | -209.84% |
| 2009 | $1.58M | $-2.77M | 36.33% | -144.62% | -175.03% |
| 2010 | $2.08M | $-1.98M | 41.14% | -66.98% | -95.30% |
| 2011 | $2.76M | $-1.96M | 50.86% | -43.85% | -70.93% |
| 2012 | $5.66M | $-1.66M | 40.48% | -16.64% | -29.31% |
| 2013 | $8.95M | $-1.08M | 42.05% | -3.19% | -12.11% |
| 2014 | $6.19M | $-3.22M | 49.03% | -50.65% | -51.98% |
| 2015 | $6.45M | $-4.21M | 59.15% | -77.80% | -65.34% |
| 2016 | $8.23M | $-6.88M | 58.09% | -58.96% | -83.57% |
| 2017 | $11.02M | $-2.52M | 61.20% | -9.58% | -22.82% |
| 2018 | $19.74M | $3.27M | 68.51% | 18.55% | 16.54% |
| 2019 | $27.37M | $-1.66M | 67.64% | -2.85% | -6.05% |
| 2020 | $48.09M | $2.67M | 57.07% | -6.93% | 5.55% |
| 2021 | $119.16M | $-8.91M | 24.21% | -29.51% | -7.48% |
| 2022 | $76.24M | $-139.81M | 61.53% | -7.77% | -183.38% |
| 2023 | $75.86M | $-66.43M | 61.63% | -30.90% | -87.57% |
| 2024 | $82.25M | $-20.18M | 65.25% | -8.67% | -24.54% |
| 2025 | $96.21M | $-12.13M | 64.56% | -12.61% | -12.61% |